Symptomatic hypoglycaemia
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive content. Let me compile a thorough answer.
Symptomatic Hypoglycaemia
Definition & Threshold
Symptomatic hypoglycaemia occurs when a falling blood glucose concentration produces symptoms. In non-diabetic adults, autonomic symptoms appear at ~60 mg/dL (3.3 mmol/L) and neuroglycopenic symptoms at ~50 mg/dL (2.8 mmol/L). In clinical practice, symptomatic hypoglycaemia in most adults occurs below 40–50 mg/dL. — ROSEN's Emergency Medicine
The glycaemic thresholds are reset lower in patients with recurrent hypoglycaemia, explaining why some individuals do not notice symptoms until glucose falls to dangerously low levels. — Goldman-Cecil Medicine
Whipple's Triad (Diagnostic Criterion)
Diagnosis requires all three:
- Symptoms consistent with hypoglycaemia
- Low plasma glucose at the time of symptoms
- Relief of symptoms with glucose administration
Classification of Hypoglycaemic Episodes (ADA/Endocrine Society)
| Category | Definition |
|---|---|
| Level 1 | Glucose 54–70 mg/dL (3.0–3.9 mmol/L); alert value, no neurocognitive impairment |
| Level 2 | Glucose <54 mg/dL (<3.0 mmol/L); clinically significant |
| Documented symptomatic | Symptoms + glucose ≤70 mg/dL |
| Severe | Any episode (regardless of glucose level) requiring third-party assistance |
| Probable symptomatic | Typical symptoms but glucose not measured |
— Goldman-Cecil Medicine
Symptoms
Symptoms arise from two mechanisms:
1. Neurogenic (Autonomic) Symptoms
Due to sympatho-adrenal activation (mainly sympathetic neural rather than adrenomedullary):
- Adrenergic: palpitations, tremor, anxiety
- Cholinergic: sweating, hunger, paraesthesias
Awareness of hypoglycaemia chiefly depends on perception of these neurogenic responses.
2. Neuroglycopenic Symptoms
Due to direct cerebral glucose deprivation:
- Dizziness, confusion, tiredness
- Difficulty speaking, inability to concentrate
- Headache
- Bizarre behaviour
- Seizures and coma
Edinburgh Hypoglycaemia Scale
| Autonomic | Neuroglycopenic | General Malaise |
|---|---|---|
| Sweating, palpitations, shaking, hunger | Confusion, drowsiness, odd behaviour, speech difficulty, incoordination | Headache, nausea |
— Goldman-Cecil Medicine
Causes
In Diabetic Patients (Iatrogenic — Most Common)
Occurs when there is a mismatch between insulin levels and carbohydrate intake, compounded by impaired counter-regulatory responses.
Risk factors (Table 210-8):
| Medical | Lifestyle |
|---|---|
| Strict glycaemic control | Increased exercise |
| Previous severe hypoglycaemia | Alcohol |
| Long duration of T1DM | Reduced carbohydrate intake |
| Renal or hepatic impairment | Missed/delayed meals |
| Impaired hypoglycaemia awareness | Gastroparesis/malabsorption |
| Sepsis, critical illness | Bariatric surgery |
| Cognitive dysfunction | Early pregnancy / breastfeeding |
Sulphonylureas and insulin carry the highest iatrogenic risk. Metformin, TZDs, DPP-4 inhibitors, and GLP-1 agonists rarely cause hypoglycaemia alone but increase risk when combined with insulin or sulphonylureas. The elderly are especially vulnerable because attenuated adrenergic symptoms allow hypoglycaemia to progress undetected.
Somogyi Phenomenon: Excessive nocturnal insulin → unrecognised hypoglycaemia → counter-regulatory rebound hyperglycaemia in the morning → clinician erroneously increases insulin dose, worsening the cycle.
Non-Diabetic Causes
| Category | Examples |
|---|---|
| Excess hormone production | Insulinoma, non-islet cell tumours secreting IGF-2 |
| Critical illness | Sepsis, multiorgan failure |
| Hepatic failure | Insufficient glycogen stores for gluconeogenesis |
| Renal failure | Decreased insulin clearance |
| Alcohol | Impairs gluconeogenesis |
| Endocrine deficiency | Hypoadrenalism, GH deficiency, hypothyroidism, hypopituitarism |
| Postprandial / reactive | Post-bariatric surgery (dumping syndrome), postvagotomy |
| Factitious | Exogenous insulin/sulphonylurea use |
| Congenital | Congenital hyperinsulinaemic hypoglycaemia |
— Goldman-Cecil Medicine
Pathophysiology of Counter-Regulatory Failure
Normal defence against hypoglycaemia:
- Cessation of insulin secretion
- Glucagon release → hepatic glycogenolysis + gluconeogenesis
- Epinephrine release → same, plus lipolysis and ketogenesis
- Cortisol and GH (permissive roles)
In long-standing T1DM, both glucagon and epinephrine responses become progressively defective, leading to hypoglycaemia unawareness — a vicious cycle where hypoglycaemia begets further hypoglycaemia. — Goldman-Cecil Medicine
Management
Mild–Moderate Symptomatic Hypoglycaemia (Patient Conscious)
- 15–20 g fast-acting oral carbohydrate (e.g., glucose tablets, fruit juice, sugary drink)
- Re-check glucose after 15 minutes; repeat if still low
- Follow with a longer-acting carbohydrate snack
Severe Hypoglycaemia (Impaired Consciousness / Cannot Self-Treat)
| Setting | Treatment |
|---|---|
| Hospital / IV access | 50 mL of 50% dextrose (D50W) IV, or 75–100 mL of 20% dextrose, followed by an infusion of 10% dextrose |
| Out of hospital / no IV | Glucagon 1 mg IM or SC (raises glucose via glycogenolysis — ineffective in depleted glycogen stores) |
| Intranasal glucagon | 3 mg nasal powder (newer option) |
After recovery: identify and correct the precipitating cause; provide a long-acting carbohydrate meal.
Sulphonylurea-Induced Hypoglycaemia
Requires prolonged monitoring (≥24 hours) because sulphonylureas have long durations of action and hypoglycaemia can recur. Octreotide (an insulin secretion inhibitor) may be used to reduce recurrent episodes.
In-Hospital Glucose Targets
- Critically ill patients: target glucose 140–180 mg/dL (7.8–10.0 mmol/L) with variable-rate IV insulin infusion
- Avoid prolonged "sliding scale" insulin — increases hypoglycaemia risk
- Resume usual home regimen when eating normally and approaching discharge
— Goldman-Cecil Medicine; ROSEN's Emergency Medicine
Hypoglycaemia Unawareness
A particularly dangerous state in which warning autonomic symptoms are absent or blunted. Causes include:
- Recurrent prior hypoglycaemic episodes (even a single episode can reduce counter-regulatory responses)
- Longer duration of T1DM
- Autonomic neuropathy
- Decreased epinephrine secretion or sensitivity
- Overly aggressive insulin therapy
Management: relax glycaemic targets, structured education, real-time or flash continuous glucose monitoring (CGM).
Key Points
- Symptomatic hypoglycaemia in diabetic patients is always iatrogenic (or due to overdose) — Goldman-Cecil
- Type 1 diabetics average 2 symptomatic episodes/week and 1 severe episode/year
- Awareness depends on neurogenic (autonomic) symptoms; neuroglycopenic symptoms are a sign of more profound hypoglycaemia
- The most common cause of diabetic coma is insulin excess relative to glucose intake — Rosen's
- Alcohol impairs gluconeogenesis and is a common precipitant, especially in fasting patients
- Severe or recurrent hypoglycaemia has cardiovascular consequences: QTc prolongation, arrhythmias, and coagulation abnormalities
This is a shared conversation. Sign in to Orris to start your own chat.